.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Julphar
Novartis
Express Scripts
AstraZeneca
Argus Health
Dow
Boehringer Ingelheim
US Department of Justice
Chinese Patent Office

Generated: December 17, 2017

DrugPatentWatch Database Preview

Silver sulfadiazine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for silver sulfadiazine and what is the scope of silver sulfadiazine freedom to operate?

Silver sulfadiazine
is the generic ingredient in five branded drugs marketed by King Pharms Llc, Dr Reddys La, Thepharmanetwork Llc, and Franklin Pharms, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-one drug master file entries for silver sulfadiazine. Twenty-four suppliers are listed for this compound.

Pharmacology for silver sulfadiazine

Ingredient-typeSulfonamides
Drug ClassSulfonamide Antibacterial

Medical Subject Heading (MeSH) Categories for silver sulfadiazine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Franklin PharmsSILDAFLOsilver sulfadiazineDRESSING;TOPICAL019608-001Nov 30, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys LaSSDsilver sulfadiazineCREAM;TOPICAL018578-001Feb 25, 1982ABRXNoNo► Subscribe► Subscribe► Subscribe
Thepharmanetwork LlcTHERMAZENEsilver sulfadiazineCREAM;TOPICAL018810-001Dec 23, 1985ABRXNoNo► Subscribe► Subscribe► Subscribe
King Pharms LlcSILVADENEsilver sulfadiazineCREAM;TOPICAL017381-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Dr Reddys LaSSD AFsilver sulfadiazineCREAM;TOPICAL018578-003Jul 11, 1990BXRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: silver sulfadiazine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
King Pharms LlcSILVADENEsilver sulfadiazineCREAM;TOPICAL017381-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Franklin PharmsSILDAFLOsilver sulfadiazineDRESSING;TOPICAL019608-001Nov 30, 1989► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Johnson and Johnson
Express Scripts
Healthtrust
Farmers Insurance
Julphar
Chubb
Merck
AstraZeneca
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot